Asset & Organizational Strategy Consulting
Our asset and organizational strategy experts work across therapeutic areas and throughout the product lifecycle to develop strategic, fit-for-purpose solutions at the asset, portfolio, and corporate levels; evaluate opportunities; and set direction to transform ideas into action.
In the biopharma sector, expert advice is vital for shaping decisions in scientific innovation. Biotech companies are major contributors to drug discovery, constituting about 60% of the US clinical pipeline and driving growth. Innovation of itself is not enough to provide value. Strategic planning is crucial to mitigate risks and demonstrate investment potential to stakeholders.
We build practical solutions to maximize portfolio and franchise valuations. Our scientific, clinical, and business development and licensing experts work across a highly diverse set of therapeutic areas, diving deeply into the dynamics of each individual disease to deliver informed recommendations. We approach each challenge with a 360-degree view to effectively guide your decision-making through meaningful insights and robust strategic thinking.
We have deep and broad experience across all major therapeutic areas. Learn more about our expertise in select key areas:
Explore select specialized solutions and cutting-edge approaches to address unique challenges across the lifecycle
Innovative Approaches and SolutionsWe would love to hear your challenge and discuss how our team of asset and organizational strategy experts can help.